Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

Inclusion criteria * Men or women of at least 18 years old. * Stable maintenance of renal replacement therapy 3 times per week. * Controlled Serum phosphate if under phosphate-binder therapy. * Serum phosphate level ≥ 6.0 mg/dL (\> 1.9 mmol/L) prior to study treatment initiation. Exclusion criteria * Peritoneal dialysis. * Parathyroidectomy or transplant scheduled during the study. * Uncontrolled hyperparathyroidism * History of hemochromatosis or ferritin \> 1000 µg/L. * Clinically significant GI disorder * Unstable medical condition other than Chronic Kidney Disease. * Treated with oral iron. * Other protocol-defined inclusion/exclusion criteria may apply.